Eli Lilly is just wrapping up trials of its retatrutide, but consumers already are flocking to black-market versions. Can ...

GLP‑1 and next‑generation obesity drugs are gaining traction across the U.S. and globally, which is good news for investors.

One in eight American adults is taking GLP-1s. What does that mean for how we relate to our food, bodies and one another?

Trump has repeatedly shown he doesn’t much care about the knock-on effect of his decisions for countries across the world.

At least 13,000 flights have been cancelled worldwide by airlines already this month - but experts have warned the worst ...

Ta’ziz, a chemical affiliate of the Abu Dhabi National Oil Co. (ADNOC), has signed an agreement with Alpha Dhabi Holding to ...

Today, however, a new growth catalyst has emerged, and it's the GLP-1 pill. Both companies recently won approval for their ...

By Sneha S K May 8 (Reuters) - Eli Lilly's new weight-loss pill, Foundayo, was prescribed 7,335 times in the U.S. in the ...

Eli Lilly (LLY) stock is in focus as U.S. prescriptions for the company's obesity pill, Foundayo, top 7,000 during the fourth ...

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It's a ...

Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...